Acute Respiratory Distress In COVID-19 Patients May Be Helped By Arthritis Med
Acute Respiratory Distress In COVID-19 Patients May Be Helped By Arthritis Med

A new study reveals a drug meant to treat rheumatoid arthritis may be of help to patients struggling to breathe due to the novel coronavirus.

According to UPI, Anakinra has been used off-label to treat patients who developed acute respiratory distress syndrome caused by COVID-19.

ARDS is the main cause of death from COVID-19.

The drug is the latest prescription medication developed for another purpose to be evaluated for use in treating COVID-19.